Headache on the Hill: What happens next

Here’s how to support migraine advocacy beyond #HOH2019 Headache on the Hill is an annual lobbying event in Washington, D.C., organized by the Alliance…
Fourth Annual Migraine World Summit

Free and online from March 20-28 The American Migraine Foundation is excited to partner with the 2019 Migraine World Summit (MWS), the largest event…
Keeping Up with Runnin’ for Research

Learn about R4R’s patient advocacy work Our partners at Runnin’ for Research (R4R) pursue a mission near and dear to our hearts: improving the…
Headache on the Hill 2019

Learn about the Alliance for Headache Disorders Advocacy’s yearly initiative Every February since 2007, headache patients, providers and advocates have descended upon Washington D.C….
4th Annual Migraine Moment Short Film Contest

Announcing a Call for Entries for the 4th Annual Migraine Moment Short Film Contest Video is one of the most compelling, and effective ways…
Year in Review: Highlighting Our Collective Wins Against Migraine

How the AMF community moved against migraine in 2018 This year, the American Migraine Foundation has been unwavering in our commitment to provide patients…
Meeting AMF Director Nim Lalvani

American Migraine Foundation Director Nim Lalvani shares her personal connection to migraine and her plans for the Foundation.
3rd Anti-CGRP Treatment Approved for Migraine

New treatment, galcanezumab (Emgality™), designed to inhibit CGRP, reduce migraine frequency Eli Lilly and Company announced late September 2018 that the U.S. Food and Drug…
AMF and AHS Respond to Proposed Changes in Insurance Billing

A recent proposal from CMS would limit patients’ access to care The Centers for Medicare and Medicaid Services (CMS) recently released a proposal that…
The 60th Annual Scientific Meeting

A recap of the groundbreaking research presented at the American Headache Society’s Scientific Meeting in San Francisco The American Headache Society’s 60th Annual Scientific…